These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10102058)

  • 1. High-dose growth hormone (GH) treatment in prepubertal GH-deficient children.
    Yokoya S; Araki K; Igarashi Y; Kohno H; Nishi Y; Hasegawa Y; Fujita K; Iwatani N; Tachibana K; Ohyama Y; Seino Y; Satoh M; Fujieda K; Tanaka T
    Acta Paediatr Suppl; 1999 Feb; 88(428):76-9. PubMed ID: 10102058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of growth hormone (GH) during puberty in GH-deficient children: preliminary results from an ongoing randomized trial with different dose regimens.
    Albertsson Wikland K; Alm F; Aronsson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson S; Kriström B; Marcus C; Moëll C; Nilsson KO; Ritzén M; Tuvemo T; Westgren U; Westphal O; Aman J
    Acta Paediatr Suppl; 1999 Feb; 88(428):80-4. PubMed ID: 10102059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.
    Lundberg E; Kriström B; Jonsson B; Albertsson-Wikland K;
    BMC Endocr Disord; 2015 Dec; 15():84. PubMed ID: 26682747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When and how to combine growth hormone with a luteinizing hormone-releasing hormone analogue.
    Tanaka T; Satoh M; Yasunaga T; Horikawa R; Tanae A; Katsumata N; Tachibana K; Nose O; Hibi I
    Acta Paediatr Suppl; 1999 Feb; 88(428):85-8. PubMed ID: 10102060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is a Two-Year Growth Response to Growth Hormone Treatment a Better Predictor of Poor Adult Height Outcome Than a First-Year Growth Response in Prepubertal Children With Growth Hormone Deficiency?
    Straetemans S; Rooman R; De Schepper J
    Front Endocrinol (Lausanne); 2021; 12():678094. PubMed ID: 34140931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The response to growth hormone treatment in prepubertal children with growth hormone deficiency in Japan: Comparing three consecutive years of treatment data of The Foundation for Growth Science in Japan between the 1990s and 2000s.
    Isojima T; Hasegawa T; Yokoya S; Tanaka T
    Endocr J; 2017 Sep; 64(9):851-858. PubMed ID: 28679975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board.
    Cutfield W; Lindberg A; Albertsson Wikland K; Chatelain P; Ranke MB; Wilton P
    Acta Paediatr Suppl; 1999 Feb; 88(428):72-5. PubMed ID: 10102057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-year efficacy and safety of LB03002, a once-weekly sustained-release growth hormone (GH) preparation, in prepubertal children with GH deficiency (GHD).
    Péter F; Bidlingmaier M; Savoy C; Ji HJ; Saenger PH
    J Clin Endocrinol Metab; 2012 Feb; 97(2):400-7. PubMed ID: 22162481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Final height in non-growth hormone deficient children treated with growth hormone. The Italian Multicentre Study Group.
    Bernasconi S; Street ME; Volta C; Mazzardo G
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):261-6; discussion 267. PubMed ID: 9373443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unfavorable effects of growth hormone therapy on the final height of boys with short stature not caused by growth hormone deficiency.
    Kawai M; Momoi T; Yorifuji T; Yamanaka C; Sasaki H; Furusho K
    J Pediatr; 1997 Feb; 130(2):205-9. PubMed ID: 9042121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone treatment of short children born small for gestational age: reappraisal of the rate of bone maturation over 2 years and metanalysis of height gain over 4 years.
    de Zegher F; Butenandt O; Chatelain P; Albertsson-Wikland K; Jonsson B; Löfström A; Chaussain JL
    Acta Paediatr Suppl; 1997 Nov; 423():207-12. PubMed ID: 9401574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone treatment of short children born small-for-gestational-age: the Nordic Multicentre Trial.
    Boguszewski M; Albertsson-Wikland K; Aronsson S; Gustafsson J; Hagenäs L; Westgren U; Westphal O; Lipsanen-Nyman M; Sipilä I; Gellert P; Müller J; Madsen B
    Acta Paediatr; 1998 Mar; 87(3):257-63. PubMed ID: 9560030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
    Kriström B; Aronson AS; Dahlgren J; Gustafsson J; Halldin M; Ivarsson SA; Nilsson NO; Svensson J; Tuvemo T; Albertsson-Wikland K
    J Clin Endocrinol Metab; 2009 Feb; 94(2):483-90. PubMed ID: 19001519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GH Dose Reduction Maintains Normal Prepubertal Height Velocity After Initial Catch-Up Growth in Short Children.
    Decker R; Albertsson-Wikland K; Kriström B; Halldin M; Gustafsson J; Nilsson NÖ; Dahlgren J
    J Clin Endocrinol Metab; 2019 Mar; 104(3):835-844. PubMed ID: 30339244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growth and cardiovascular effects of high dose growth hormone therapy in idiopathic short stature.
    Barton JS; Gardineri HM; Cullen S; Hindmarsh PC; Brook CG; Preece MA
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):619-26. PubMed ID: 7634503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final height of growth hormone-treated GH-deficient children and girls with Turner's syndrome: the Dutch experience. The Dutch Advisory Group on Growth Hormone.
    de Muinck Keizer-Schrama S; Van den Broeck J; Sas T; Hokken-Koelega A
    Horm Res; 1999; 51 Suppl 3():127-31. PubMed ID: 10592457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical markers of growth hormone (GH) sensitivity in children with idiopathic short stature: individual capacity of IGF-I generation after high-dose GH treatment determines the growth response to GH.
    Kamp GA; Zwinderman AH; Van Doorn J; Hackeng W; Frölich M; Schönau E; Wit JM
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):315-25. PubMed ID: 12201823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response study of biosynthetic human growth hormone (GH) in GH-deficient children: effects on auxological and biochemical parameters. Dutch Growth Hormone Working Group.
    de Muinck Keizer-Schrama SM; Rikken B; Wynne HJ; Hokken-Koelega AC; Wit JM; Bot A; Drop SL
    J Clin Endocrinol Metab; 1992 Apr; 74(4):898-905. PubMed ID: 1548357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
    Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature.
    Kamp GA; Waelkens JJ; de Muinck Keizer-Schrama SM; Delemarre-Van de Waal HA; Verhoeven-Wind L; Zwinderman AH; Wit JM
    Arch Dis Child; 2002 Sep; 87(3):215-20. PubMed ID: 12193430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.